Is dexmethylphenidate (Azstarys) available in China?

Dexmethylphenidate (Azstarys) is a prescription drug for attention deficit hyperactivity disorder (ADHD) for children and adolescents 6 years of age and older. Its main purpose is to improve concentration, reduce impulsive behavior and hyperactivity, thereby helping patients adapt better in academic, family and social environments. By acting on the dopamine and norepinephrine systems in the brain, Azstarys can regulate nerve signal transmission, significantly improving patients' executive functions and self-control abilities.

Currently,Azstarys has not been officially launched in mainland China, so domestic patients cannot obtain it directly through local hospital pharmacies. For patients or parents with clinical needs, the drug can only be obtained through overseas channels or legal import channels. This also means that you need to fully understand overseas drug purchase policies, drug storage conditions and transportation safety before use to ensure the safety and effectiveness of medication. At the same time, patients should be evaluated by a professional doctor before using Azstarys, including the severity of ADHD symptoms, previous medication history and potential contraindications, to develop an individualized treatment plan.

In overseas markets,Azstarys has been approved by the FDA, and clinical studies have shown that it has reliable efficacy in improving ADHD symptoms in children and adolescents. Compared with traditional methylphenidate drugs, its unique combination of sustained-release and immediate-release dosage forms helps maintain drug efficacy throughout the day, improves concentration during the day, reduces the number of medication doses, and improves compliance. As an innovative ADHD treatment drug, Azstarys provides a new option for clinical use, especially for patients who have poor response or tolerance to traditional treatments.

Overall,Azstarys is mainly used to improve ADHD-related symptoms, but it has not yet been marketed in China. If patients need to use this drug, they must go through legal overseas channels and develop an individualized treatment plan under the guidance of a professional doctor to ensure efficacy and safety.

Reference materials:https://azstarys.com/